Clinician Job Satisfaction After Peer Comparison Feedback
A Secondary Analysis of a Randomized Clinical Trial
Cancer Drug Trastuzumab And Its Biosimilars Compete On Price For Market Share
Using Medicare claims, Schaeffer experts documented US prescribing patterns for originator biologic trastuzumab (Herceptin), a targeted cancer therapy, and five biosimilar entrants since 2019.
Citizenship status and cost-related nonadherence in the United States, 2017–2021
Noncitizens experience a high burden of cost-related barriers to prescription medications.
Cross-Sectional Study Examining Household Factors Associated with SARS-CoV-2 Seropositivity in Low-Income Children in L.A.
Food insecure households with low head-of-household education, and at least one household member with type 2 diabetes, had the highest risk of SARS-CoV-2.
Examining Policies that Inhibit Innovation and Patient Access
Americans have benefited substantially from new medical treatments, and the United States serves as the engine of medical innovation for the world.
Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients
Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality.
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative
The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.
Expanding the Use of Brief Cognitive Assessments to Detect Suspected Early-Stage Cognitive Impairment in Primary Care
Providing primary care clinicians with suitable assessment tools, integrating brief cognitive assessments into routine workflows, and crafting payment policies to encourage adoption of assessments would all help improve detection.
Benefits of Medicare Coverage for Weight Loss Drugs
The cumulative social benefits from Medicare coverage for new obesity treatments over the next 10 years would reach almost $1 trillion, or roughly $100 billion per year.Categorized in
Role of Parents’ Perceived Risk and Responsibility in Deciding on Children’s COVID-19 Vaccination
Parents’ perceptions of the COVID-19 vaccine’s long-term comparative risk and their greater anticipated responsibility for children getting sick if vaccinated (versus not) were associated with lower vaccine uptake among children of vaccinated parents.